CVS Pays $5M To End Whistleblower's Medicare Fraud Claims
CVS Caremark Corp. will pay $5.25 million to settle patient whistleblower allegations that it submitted false prices for certain Medicare prescription drugs that caused some patients to pay significantly more for...To view the full article, register now.
Already a subscriber? Click here to view full article